1. Home
  2. CVGI vs ELTX Comparison

CVGI vs ELTX Comparison

Compare CVGI & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$4.51

Market Cap

167.7M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$3.20

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
ELTX
Founded
2000
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.7M
185.4M
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
CVGI
ELTX
Price
$4.51
$3.20
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$18.00
AVG Volume (30 Days)
657.7K
3.7M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
316.18
39.29
EPS
0.04
N/A
Revenue
$755,231,000.00
$2,301,000.00
Revenue This Year
$4.84
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$110.00
N/A
Revenue Growth
14.06
N/A
52 Week Low
$1.29
$2.66
52 Week High
$5.88
$16.00

Technical Indicators

Market Signals
Indicator
CVGI
ELTX
Relative Strength Index (RSI) 41.13 33.88
Support Level $3.73 $2.66
Resistance Level $4.45 $9.44
Average True Range (ATR) 0.40 0.96
MACD -0.07 -0.22
Stochastic Oscillator 8.15 4.58

Price Performance

Historical Comparison
CVGI
ELTX

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: